|
马上注册登录,享用更多感控资源,助你轻松入门。
您需要 登录 才可以下载或查看,没有账号?注册
|
×
Volume 8, Issue 12, December 2008, Pages 751-762
Copyright © 2008 Elsevier Ltd All rights reserved. Review Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
多重耐药鲍曼控制和治疗进展
Drosos E Karageorgopoulos MDa and Dr Matthew E Falagas MDa, b, c, ,
aAlfa Institute of Biomedical Sciences (AIBS), Athens, Greece
bDepartment of Medicine, Henry Dunant Hospital, Athens, Greece
cDepartment of Medicine, Tufts University School of Medicine, Boston, MA, USA
Available online 17 November 2008.
SummaryInstitutional outbreaks caused by Acinetobacter baumannii strains that have acquired multiple mechanisms of antimicrobial drug resistance constitute a growing public-health problem. Because of complex epidemiology, infection control of these outbreaks is difficult to attain. Identification of potential common sources of an outbreak, through surveillance cultures and epidemiological typing studies, can aid in the implementation of specific control measures. Adherence to a series of infection control methods including strict environmental cleaning, effective sterilisation of reusable medical equipment, attention to proper hand hygiene practices, and use of contact precautions, together with appropriate administrative guidance and support, are required for the containment of an outbreak. Effective antibiotic treatment of A baumannii infections, such as ventilator-associated pneumonia and bloodstream infections, is also of paramount importance. Carbapenems have long been regarded as the agents of choice, but resistance rates have risen substantially in some areas. Sulbactam has been successfully used in the treatment of serious A baumannii infections; however, the activity of this agent against carbapenem-resistant isolates is decreasing. Polymyxins show reliable antimicrobial activity against A baumannii isolates. Available clinical reports, although consisting of small-sized studies, support their effectiveness and mitigate previous concerns for toxicity. Minocycline, and particularly its derivative, tigecycline, have shown high antimicrobial activity against A baumannii, though relevant clinical evidence is still scarce. Several issues regarding the optimum therapeutic choices for multidrug-resistant A baumannii infections need to be clarified by future research.
Article OutlineIntroduction Control of outbreaks of multidrug-resistant A baumannii Ability to cause outbreaks Epidemiology of outbreaks Epidemiological analysis of an outbreak Potential common sources Risk factors for acquisition of outbreak strains Infection control measuresTreatment of multidrug-resistant A baumannii infections Pathogenicity of A baumannii and infection outcomes Antimicrobial therapy Carbapenems Polymyxins Sulbactam Tetracyclines and glycylcyclines Aminoglycosides Fluoroquinolones Combination therapyFuture prospects Conclusions Search strategy and selection criteria References |
评分
-
查看全部评分
|